跳至主要内容
临床试验/EUCTR2008-002647-16-GB
EUCTR2008-002647-16-GB进行中(未招募)不适用

Assessment of blood glucose profile in type 2 diabetic patients after a one-week treatment with gliclazide 60 mg MR using both the glycaemic Holter method and multiple blood glucose samples.A double-blind, randomized, parallel group, placebo-controlled, exploratory study.

Institut de Recherches Internationales Servier0 个研究点开始时间: 2008年11月4日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • . Type 2 diabetic patients
  • . Between 35 and 70 years of age inclusive,
  • . Diagnosed with diabetes for at least 3 months,
  • . Body Mass Index (BMI) between 24 and 38 kg/m2 inclusive,
  • . Currently treated with metformin alone.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • · Pregnancy, breast-feeding or female of childbearing potential not using appropriate contraception,
  • · Special diet or substantial changes in eating habits in the last 3 months,
  • . Type 1 diabetes.

研究者

相似试验